chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Angiogram, Anxiety, Blood glucose decreased, Blood test, Chest X-ray
Clinical narrative: headache; This is a spontaneous report from a contactable consumer. A 68-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via an unspecified route of administration on 17Feb2021 ( as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced headache on an unknown date in 2021. The headache is ongoing for the past 6 days and it is not going away. Tylenol is not helping. She planned to contact her primary care provider for further discussion. Therapeutic measures were taken as a result of headache. The outcome of the event was not resolved.  Information about Lot/batch number has been requested.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Electrocardiogram, Headache, Hypertension, Insomnia, Magnetic resonance imaging
Clinical narrative: headache; This is a spontaneous report from a contactable consumer. A 68-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via an unspecified route of administration on 17Feb2021 ( as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced headache on an unknown date in 2021. The headache is ongoing for the past 6 days and it is not going away. Tylenol is not helping. She planned to contact her primary care provider for further discussion. Therapeutic measures were taken as a result of headache. The outcome of the event was not resolved.  Information about Lot/batch number has been requested.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache
Clinical narrative: headache; This is a spontaneous report from a contactable consumer. A 68-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via an unspecified route of administration on 17Feb2021 ( as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced headache on an unknown date in 2021. The headache is ongoing for the past 6 days and it is not going away. Tylenol is not helping. She planned to contact her primary care provider for further discussion. Therapeutic measures were taken as a result of headache. The outcome of the event was not resolved.  Information about Lot/batch number has been requested.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Hypoaesthesia oral
Clinical narrative: lip area looked a little droop; numbness around her mouth area that spread to the left cheek area; soreness/pain in the arm after the injection; This is a spontaneous report from a contactable consumer (patient). A 45-year-old female patient received the first dose of bnt162b2 (BNT162B2, Solution for injection, lot number was not reported), via an unspecified route of administration on 05Mar2021 (received at 45-years-old) at a single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient received the first dose of the Pfizer Covid 19 vaccine at noon on 05Mar2021. She stated that 18 hours later, when she woke up the next morning on 06Mar2021, she had numbness around her mouth area that spread to the left cheek area. She said it was like going to the dentist and getting local anesthesia for a filling. Her lip area looked a little droopy, but she wasn't sure. It continued the whole day and reduced the next day (07Mar2021). She also had soreness/pain in the arm after the injection (05Mar2021) and the next morning (06Mar2021). She further stated that her doctor wasn't sure if this was a one-time issue or related to the vaccine. Outcome of Her lip area looked a little droopy was recovering, while outcome of the other events was unknown.  Information about batch/lot number has been requested.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Facial paresis, Hypoaesthesia, Pain in extremity
Clinical narrative: lip area looked a little droop; numbness around her mouth area that spread to the left cheek area; soreness/pain in the arm after the injection; This is a spontaneous report from a contactable consumer (patient). A 45-year-old female patient received the first dose of bnt162b2 (BNT162B2, Solution for injection, lot number was not reported), via an unspecified route of administration on 05Mar2021 (received at 45-years-old) at a single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient received the first dose of the Pfizer Covid 19 vaccine at noon on 05Mar2021. She stated that 18 hours later, when she woke up the next morning on 06Mar2021, she had numbness around her mouth area that spread to the left cheek area. She said it was like going to the dentist and getting local anesthesia for a filling. Her lip area looked a little droopy, but she wasn't sure. It continued the whole day and reduced the next day (07Mar2021). She also had soreness/pain in the arm after the injection (05Mar2021) and the next morning (06Mar2021). She further stated that her doctor wasn't sure if this was a one-time issue or related to the vaccine. Outcome of Her lip area looked a little droopy was recovering, while outcome of the other events was unknown.  Information about batch/lot number has been requested.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Facial paralysis, Hypoaesthesia oral, Pain in extremity
Clinical narrative: lip area looked a little droop; numbness around her mouth area that spread to the left cheek area; soreness/pain in the arm after the injection; This is a spontaneous report from a contactable consumer (patient). A 45-year-old female patient received the first dose of bnt162b2 (BNT162B2, Solution for injection, lot number was not reported), via an unspecified route of administration on 05Mar2021 (received at 45-years-old) at a single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient received the first dose of the Pfizer Covid 19 vaccine at noon on 05Mar2021. She stated that 18 hours later, when she woke up the next morning on 06Mar2021, she had numbness around her mouth area that spread to the left cheek area. She said it was like going to the dentist and getting local anesthesia for a filling. Her lip area looked a little droopy, but she wasn't sure. It continued the whole day and reduced the next day (07Mar2021). She also had soreness/pain in the arm after the injection (05Mar2021) and the next morning (06Mar2021). She further stated that her doctor wasn't sure if this was a one-time issue or related to the vaccine. Outcome of Her lip area looked a little droopy was recovering, while outcome of the other events was unknown.  Information about batch/lot number has been requested.
Age: 42.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Back pain, Chills, Pyrexia
Clinical narrative: small pneumonia in lower left lung; Light headedness; racing heartbeat; Moderate chest pressure when breathing; work up with terrible thoracic back pain with every breath; chills; low grade fever; Moderate stomach cramps; Much less arm pain then following first dose but still present; This is a spontaneous report from a contactable consumer (patient). A 42-year-old male patient received second dose of BNT162B2, (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EN6203) via an unspecified route of administration in left arm on 03Mar2021 (at the age of 42-year-old) at single dose for COVID-19 immunisation. There was no medical history. The patient had no known allergies. The patient had previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9267) on 10Feb2021 at 11:30 am in left arm for Covid-19 immunisation. There were no other vaccines in four weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had 3/4 moderate stomach cramps day after vaccine on 04Mar2021. Much less arm pain then following first dose but still present on 04Mar2021. The patient 3/9 worked up with terrible thoracic back pain on 09Mar2021 with every breath and went to emergency room and received shot of Toradol and performed chest x-ray which was negative. Shortly thereafter, the patient had chills and low grade fever on 09Mar2021. Alternated naproxen and tylenol for the next two days as fever persisted. The patient had 3/11 moderate chest pressure when breathing and went back to emergency room on 11Mar2021. There was no fever or chills but had 3/12 light headedness, racing heartbeat and chills early afternoon on 12Mar2021. The patient went back to emergency room. The patient's symptoms improved over course of following 7 days. The patient underwent lab test and procedure which included flu test and resulted negative; blood work which showed positive D-dimer test on an unknown date and CT scan showed small pneumonia in lower left lung on 12Mar2021. The patient started to receive amoxicillin and Z-pack. Since the vaccination, the patient had been tested for COVID-19 by nasal swab on 11Mar2021 and tested negative. Events resulted in emergency room/department or urgent care. The outcome of event pneumonia was unknown; for other events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 42.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Abdominal pain upper, Back pain, Chest X-ray normal, Chest discomfort, Chills
Clinical narrative: small pneumonia in lower left lung; Light headedness; racing heartbeat; Moderate chest pressure when breathing; work up with terrible thoracic back pain with every breath; chills; low grade fever; Moderate stomach cramps; Much less arm pain then following first dose but still present; This is a spontaneous report from a contactable consumer (patient). A 42-year-old male patient received second dose of BNT162B2, (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EN6203) via an unspecified route of administration in left arm on 03Mar2021 (at the age of 42-year-old) at single dose for COVID-19 immunisation. There was no medical history. The patient had no known allergies. The patient had previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9267) on 10Feb2021 at 11:30 am in left arm for Covid-19 immunisation. There were no other vaccines in four weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had 3/4 moderate stomach cramps day after vaccine on 04Mar2021. Much less arm pain then following first dose but still present on 04Mar2021. The patient 3/9 worked up with terrible thoracic back pain on 09Mar2021 with every breath and went to emergency room and received shot of Toradol and performed chest x-ray which was negative. Shortly thereafter, the patient had chills and low grade fever on 09Mar2021. Alternated naproxen and tylenol for the next two days as fever persisted. The patient had 3/11 moderate chest pressure when breathing and went back to emergency room on 11Mar2021. There was no fever or chills but had 3/12 light headedness, racing heartbeat and chills early afternoon on 12Mar2021. The patient went back to emergency room. The patient's symptoms improved over course of following 7 days. The patient underwent lab test and procedure which included flu test and resulted negative; blood work which showed positive D-dimer test on an unknown date and CT scan showed small pneumonia in lower left lung on 12Mar2021. The patient started to receive amoxicillin and Z-pack. Since the vaccination, the patient had been tested for COVID-19 by nasal swab on 11Mar2021 and tested negative. Events resulted in emergency room/department or urgent care. The outcome of event pneumonia was unknown; for other events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 42.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Computerised tomogram abnormal, Dizziness, Fibrin D dimer increased, Influenza virus test negative, Pain in extremity
Clinical narrative: small pneumonia in lower left lung; Light headedness; racing heartbeat; Moderate chest pressure when breathing; work up with terrible thoracic back pain with every breath; chills; low grade fever; Moderate stomach cramps; Much less arm pain then following first dose but still present; This is a spontaneous report from a contactable consumer (patient). A 42-year-old male patient received second dose of BNT162B2, (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EN6203) via an unspecified route of administration in left arm on 03Mar2021 (at the age of 42-year-old) at single dose for COVID-19 immunisation. There was no medical history. The patient had no known allergies. The patient had previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9267) on 10Feb2021 at 11:30 am in left arm for Covid-19 immunisation. There were no other vaccines in four weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had 3/4 moderate stomach cramps day after vaccine on 04Mar2021. Much less arm pain then following first dose but still present on 04Mar2021. The patient 3/9 worked up with terrible thoracic back pain on 09Mar2021 with every breath and went to emergency room and received shot of Toradol and performed chest x-ray which was negative. Shortly thereafter, the patient had chills and low grade fever on 09Mar2021. Alternated naproxen and tylenol for the next two days as fever persisted. The patient had 3/11 moderate chest pressure when breathing and went back to emergency room on 11Mar2021. There was no fever or chills but had 3/12 light headedness, racing heartbeat and chills early afternoon on 12Mar2021. The patient went back to emergency room. The patient's symptoms improved over course of following 7 days. The patient underwent lab test and procedure which included flu test and resulted negative; blood work which showed positive D-dimer test on an unknown date and CT scan showed small pneumonia in lower left lung on 12Mar2021. The patient started to receive amoxicillin and Z-pack. Since the vaccination, the patient had been tested for COVID-19 by nasal swab on 11Mar2021 and tested negative. Events resulted in emergency room/department or urgent care. The outcome of event pneumonia was unknown; for other events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 42.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Palpitations, Pneumonia, Pyrexia, SARS-CoV-2 test negative
Clinical narrative: small pneumonia in lower left lung; Light headedness; racing heartbeat; Moderate chest pressure when breathing; work up with terrible thoracic back pain with every breath; chills; low grade fever; Moderate stomach cramps; Much less arm pain then following first dose but still present; This is a spontaneous report from a contactable consumer (patient). A 42-year-old male patient received second dose of BNT162B2, (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EN6203) via an unspecified route of administration in left arm on 03Mar2021 (at the age of 42-year-old) at single dose for COVID-19 immunisation. There was no medical history. The patient had no known allergies. The patient had previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9267) on 10Feb2021 at 11:30 am in left arm for Covid-19 immunisation. There were no other vaccines in four weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had 3/4 moderate stomach cramps day after vaccine on 04Mar2021. Much less arm pain then following first dose but still present on 04Mar2021. The patient 3/9 worked up with terrible thoracic back pain on 09Mar2021 with every breath and went to emergency room and received shot of Toradol and performed chest x-ray which was negative. Shortly thereafter, the patient had chills and low grade fever on 09Mar2021. Alternated naproxen and tylenol for the next two days as fever persisted. The patient had 3/11 moderate chest pressure when breathing and went back to emergency room on 11Mar2021. There was no fever or chills but had 3/12 light headedness, racing heartbeat and chills early afternoon on 12Mar2021. The patient went back to emergency room. The patient's symptoms improved over course of following 7 days. The patient underwent lab test and procedure which included flu test and resulted negative; blood work which showed positive D-dimer test on an unknown date and CT scan showed small pneumonia in lower left lung on 12Mar2021. The patient started to receive amoxicillin and Z-pack. Since the vaccination, the patient had been tested for COVID-19 by nasal swab on 11Mar2021 and tested negative. Events resulted in emergency room/department or urgent care. The outcome of event pneumonia was unknown; for other events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 42.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Abdominal pain upper, Back pain, Blood test, COVID-19, Chest X-ray
Clinical narrative: small pneumonia in lower left lung; Light headedness; racing heartbeat; Moderate chest pressure when breathing; work up with terrible thoracic back pain with every breath; chills; low grade fever; Moderate stomach cramps; Much less arm pain then following first dose but still present; This is a spontaneous report from a contactable consumer (patient). A 42-year-old male patient received second dose of BNT162B2, (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EN6203) via an unspecified route of administration in left arm on 03Mar2021 (at the age of 42-year-old) at single dose for COVID-19 immunisation. There was no medical history. The patient had no known allergies. The patient had previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9267) on 10Feb2021 at 11:30 am in left arm for Covid-19 immunisation. There were no other vaccines in four weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had 3/4 moderate stomach cramps day after vaccine on 04Mar2021. Much less arm pain then following first dose but still present on 04Mar2021. The patient 3/9 worked up with terrible thoracic back pain on 09Mar2021 with every breath and went to emergency room and received shot of Toradol and performed chest x-ray which was negative. Shortly thereafter, the patient had chills and low grade fever on 09Mar2021. Alternated naproxen and tylenol for the next two days as fever persisted. The patient had 3/11 moderate chest pressure when breathing and went back to emergency room on 11Mar2021. There was no fever or chills but had 3/12 light headedness, racing heartbeat and chills early afternoon on 12Mar2021. The patient went back to emergency room. The patient's symptoms improved over course of following 7 days. The patient underwent lab test and procedure which included flu test and resulted negative; blood work which showed positive D-dimer test on an unknown date and CT scan showed small pneumonia in lower left lung on 12Mar2021. The patient started to receive amoxicillin and Z-pack. Since the vaccination, the patient had been tested for COVID-19 by nasal swab on 11Mar2021 and tested negative. Events resulted in emergency room/department or urgent care. The outcome of event pneumonia was unknown; for other events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 42.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chest discomfort, Chills, Computerised tomogram, Dizziness, Heart rate increased
Clinical narrative: small pneumonia in lower left lung; Light headedness; racing heartbeat; Moderate chest pressure when breathing; work up with terrible thoracic back pain with every breath; chills; low grade fever; Moderate stomach cramps; Much less arm pain then following first dose but still present; This is a spontaneous report from a contactable consumer (patient). A 42-year-old male patient received second dose of BNT162B2, (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EN6203) via an unspecified route of administration in left arm on 03Mar2021 (at the age of 42-year-old) at single dose for COVID-19 immunisation. There was no medical history. The patient had no known allergies. The patient had previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9267) on 10Feb2021 at 11:30 am in left arm for Covid-19 immunisation. There were no other vaccines in four weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had 3/4 moderate stomach cramps day after vaccine on 04Mar2021. Much less arm pain then following first dose but still present on 04Mar2021. The patient 3/9 worked up with terrible thoracic back pain on 09Mar2021 with every breath and went to emergency room and received shot of Toradol and performed chest x-ray which was negative. Shortly thereafter, the patient had chills and low grade fever on 09Mar2021. Alternated naproxen and tylenol for the next two days as fever persisted. The patient had 3/11 moderate chest pressure when breathing and went back to emergency room on 11Mar2021. There was no fever or chills but had 3/12 light headedness, racing heartbeat and chills early afternoon on 12Mar2021. The patient went back to emergency room. The patient's symptoms improved over course of following 7 days. The patient underwent lab test and procedure which included flu test and resulted negative; blood work which showed positive D-dimer test on an unknown date and CT scan showed small pneumonia in lower left lung on 12Mar2021. The patient started to receive amoxicillin and Z-pack. Since the vaccination, the patient had been tested for COVID-19 by nasal swab on 11Mar2021 and tested negative. Events resulted in emergency room/department or urgent care. The outcome of event pneumonia was unknown; for other events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 42.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Investigation, Pain in extremity, Pneumonia, Pyrexia
Clinical narrative: small pneumonia in lower left lung; Light headedness; racing heartbeat; Moderate chest pressure when breathing; work up with terrible thoracic back pain with every breath; chills; low grade fever; Moderate stomach cramps; Much less arm pain then following first dose but still present; This is a spontaneous report from a contactable consumer (patient). A 42-year-old male patient received second dose of BNT162B2, (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EN6203) via an unspecified route of administration in left arm on 03Mar2021 (at the age of 42-year-old) at single dose for COVID-19 immunisation. There was no medical history. The patient had no known allergies. The patient had previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9267) on 10Feb2021 at 11:30 am in left arm for Covid-19 immunisation. There were no other vaccines in four weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had 3/4 moderate stomach cramps day after vaccine on 04Mar2021. Much less arm pain then following first dose but still present on 04Mar2021. The patient 3/9 worked up with terrible thoracic back pain on 09Mar2021 with every breath and went to emergency room and received shot of Toradol and performed chest x-ray which was negative. Shortly thereafter, the patient had chills and low grade fever on 09Mar2021. Alternated naproxen and tylenol for the next two days as fever persisted. The patient had 3/11 moderate chest pressure when breathing and went back to emergency room on 11Mar2021. There was no fever or chills but had 3/12 light headedness, racing heartbeat and chills early afternoon on 12Mar2021. The patient went back to emergency room. The patient's symptoms improved over course of following 7 days. The patient underwent lab test and procedure which included flu test and resulted negative; blood work which showed positive D-dimer test on an unknown date and CT scan showed small pneumonia in lower left lung on 12Mar2021. The patient started to receive amoxicillin and Z-pack. Since the vaccination, the patient had been tested for COVID-19 by nasal swab on 11Mar2021 and tested negative. Events resulted in emergency room/department or urgent care. The outcome of event pneumonia was unknown; for other events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Herpes zoster, Pain, Pruritus
Clinical narrative: outbreak of shingles; This is a spontaneous report from a contactable consumer reported for herself.  A 71-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot number: EN6208), at left arm via an unspecified route of administration, on 08Mar2021 08:30 (at 71-years age) as single dose for COVID-19 immunisation. Medical history included polycythaemia and gastrooesophageal reflux disease. Concomitant medications included 500mg valacyclovir, 20mg omeprazole and propranolol. The patient has allergy to DEPAKOTE. On 09Mar2021 at 10:00 (following morn), the patient experienced outbreak of shingles (haven't had one for several years) but do take a mild dose of anti-viral to prevent it. Her physician, and hematologist were not sure if I could take the valacyclovir dosage to counter-act. No treatment received for the adverse event. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination and after vaccination patient was not diagnosed with COVID-19. Patient was not tested for COVID-19. It was reported that the patient currently running other test for lymph issues. The outcome of the event was not recovered.
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Herpes zoster, Investigation
Clinical narrative: outbreak of shingles; This is a spontaneous report from a contactable consumer reported for herself.  A 71-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot number: EN6208), at left arm via an unspecified route of administration, on 08Mar2021 08:30 (at 71-years age) as single dose for COVID-19 immunisation. Medical history included polycythaemia and gastrooesophageal reflux disease. Concomitant medications included 500mg valacyclovir, 20mg omeprazole and propranolol. The patient has allergy to DEPAKOTE. On 09Mar2021 at 10:00 (following morn), the patient experienced outbreak of shingles (haven't had one for several years) but do take a mild dose of anti-viral to prevent it. Her physician, and hematologist were not sure if I could take the valacyclovir dosage to counter-act. No treatment received for the adverse event. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination and after vaccination patient was not diagnosed with COVID-19. Patient was not tested for COVID-19. It was reported that the patient currently running other test for lymph issues. The outcome of the event was not recovered.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram, Dyspnoea, Fibrin D dimer increased, Tachycardia, Thrombosis
Clinical narrative: Thrombosis pulmonary; This is a spontaneous report from a contactable consumer. A 69-year-old female patient received bnt162b2 (BNT162B2), via an unspecified route of administration on 09Feb2021 as SINGLE DOSE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced thrombosis pulmonary. Outcome of the event was unknown.   Information on the lot/batch number has been requested.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pulmonary thrombosis
Clinical narrative: Thrombosis pulmonary; This is a spontaneous report from a contactable consumer. A 69-year-old female patient received bnt162b2 (BNT162B2), via an unspecified route of administration on 09Feb2021 as SINGLE DOSE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced thrombosis pulmonary. Outcome of the event was unknown.   Information on the lot/batch number has been requested.
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chills, Heart rate increased, Hypoaesthesia, Malaise, Nausea
Clinical narrative: high fevers (102 °F); headaches; chills; Triggered a urinary tract infection in me; hotflashes; elevated my heart rate (103 bpm); could not stop shaking; This is a spontaneous report from a contactable consumer (patient). A 63-year-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 17Mar2021 14:30 (Batch/Lot Number: EN6199) as SINGLE DOSE for COVID-19 immunization.  Medical history included urinary tract infection (unknown if ongoing). Concomitant medications were not reported. The patient had the first dose was on 17Mar2021 at around 2:30. The next day, he had high fevers (102 degrees F), headaches and chills, hot flashes, elevated his heart rate (103 bpm) and could not stop shaking. The patient also mentioned that the vaccine triggered a urinary tract infection in him. The patient was then sent to emergency room at 4 o'clock. Outcome of the events were unknown.  No follow-up attempts are possible. No further information is expected.  Follow-up attempts are completed. No further information is expected.
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Oxygen saturation decreased, Paraesthesia, Pyrexia, Vertigo
Clinical narrative: high fevers (102 °F); headaches; chills; Triggered a urinary tract infection in me; hotflashes; elevated my heart rate (103 bpm); could not stop shaking; This is a spontaneous report from a contactable consumer (patient). A 63-year-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 17Mar2021 14:30 (Batch/Lot Number: EN6199) as SINGLE DOSE for COVID-19 immunization.  Medical history included urinary tract infection (unknown if ongoing). Concomitant medications were not reported. The patient had the first dose was on 17Mar2021 at around 2:30. The next day, he had high fevers (102 degrees F), headaches and chills, hot flashes, elevated his heart rate (103 bpm) and could not stop shaking. The patient also mentioned that the vaccine triggered a urinary tract infection in him. The patient was then sent to emergency room at 4 o'clock. Outcome of the events were unknown.  No follow-up attempts are possible. No further information is expected.  Follow-up attempts are completed. No further information is expected.
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood test, Body temperature increased, Chest X-ray, Chills, Electrocardiogram
Clinical narrative: high fevers (102 °F); headaches; chills; Triggered a urinary tract infection in me; hotflashes; elevated my heart rate (103 bpm); could not stop shaking; This is a spontaneous report from a contactable consumer (patient). A 63-year-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 17Mar2021 14:30 (Batch/Lot Number: EN6199) as SINGLE DOSE for COVID-19 immunization.  Medical history included urinary tract infection (unknown if ongoing). Concomitant medications were not reported. The patient had the first dose was on 17Mar2021 at around 2:30. The next day, he had high fevers (102 degrees F), headaches and chills, hot flashes, elevated his heart rate (103 bpm) and could not stop shaking. The patient also mentioned that the vaccine triggered a urinary tract infection in him. The patient was then sent to emergency room at 4 o'clock. Outcome of the events were unknown.  No follow-up attempts are possible. No further information is expected.  Follow-up attempts are completed. No further information is expected.
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Erythema, Headache, Heart rate increased, Hypoaesthesia, Malaise
Clinical narrative: high fevers (102 °F); headaches; chills; Triggered a urinary tract infection in me; hotflashes; elevated my heart rate (103 bpm); could not stop shaking; This is a spontaneous report from a contactable consumer (patient). A 63-year-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 17Mar2021 14:30 (Batch/Lot Number: EN6199) as SINGLE DOSE for COVID-19 immunization.  Medical history included urinary tract infection (unknown if ongoing). Concomitant medications were not reported. The patient had the first dose was on 17Mar2021 at around 2:30. The next day, he had high fevers (102 degrees F), headaches and chills, hot flashes, elevated his heart rate (103 bpm) and could not stop shaking. The patient also mentioned that the vaccine triggered a urinary tract infection in him. The patient was then sent to emergency room at 4 o'clock. Outcome of the events were unknown.  No follow-up attempts are possible. No further information is expected.  Follow-up attempts are completed. No further information is expected.
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Mobility decreased, Nausea, Pyrexia, Urinary tract infection, Viral test
Clinical narrative: high fevers (102 °F); headaches; chills; Triggered a urinary tract infection in me; hotflashes; elevated my heart rate (103 bpm); could not stop shaking; This is a spontaneous report from a contactable consumer (patient). A 63-year-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 17Mar2021 14:30 (Batch/Lot Number: EN6199) as SINGLE DOSE for COVID-19 immunization.  Medical history included urinary tract infection (unknown if ongoing). Concomitant medications were not reported. The patient had the first dose was on 17Mar2021 at around 2:30. The next day, he had high fevers (102 degrees F), headaches and chills, hot flashes, elevated his heart rate (103 bpm) and could not stop shaking. The patient also mentioned that the vaccine triggered a urinary tract infection in him. The patient was then sent to emergency room at 4 o'clock. Outcome of the events were unknown.  No follow-up attempts are possible. No further information is expected.  Follow-up attempts are completed. No further information is expected.
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Body temperature, Chills, Headache, Heart rate, Heart rate increased
Clinical narrative: high fevers (102 °F); headaches; chills; Triggered a urinary tract infection in me; hotflashes; elevated my heart rate (103 bpm); could not stop shaking; This is a spontaneous report from a contactable consumer (patient). A 63-year-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 17Mar2021 14:30 (Batch/Lot Number: EN6199) as SINGLE DOSE for COVID-19 immunization.  Medical history included urinary tract infection (unknown if ongoing). Concomitant medications were not reported. The patient had the first dose was on 17Mar2021 at around 2:30. The next day, he had high fevers (102 degrees F), headaches and chills, hot flashes, elevated his heart rate (103 bpm) and could not stop shaking. The patient also mentioned that the vaccine triggered a urinary tract infection in him. The patient was then sent to emergency room at 4 o'clock. Outcome of the events were unknown.  No follow-up attempts are possible. No further information is expected.  Follow-up attempts are completed. No further information is expected.
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Hot flush, Pyrexia, Tremor, Urinary tract infection
Clinical narrative: high fevers (102 °F); headaches; chills; Triggered a urinary tract infection in me; hotflashes; elevated my heart rate (103 bpm); could not stop shaking; This is a spontaneous report from a contactable consumer (patient). A 63-year-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 17Mar2021 14:30 (Batch/Lot Number: EN6199) as SINGLE DOSE for COVID-19 immunization.  Medical history included urinary tract infection (unknown if ongoing). Concomitant medications were not reported. The patient had the first dose was on 17Mar2021 at around 2:30. The next day, he had high fevers (102 degrees F), headaches and chills, hot flashes, elevated his heart rate (103 bpm) and could not stop shaking. The patient also mentioned that the vaccine triggered a urinary tract infection in him. The patient was then sent to emergency room at 4 o'clock. Outcome of the events were unknown.  No follow-up attempts are possible. No further information is expected.  Follow-up attempts are completed. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test, Chest pain, Computerised tomogram, Dizziness, Ear congestion
Clinical narrative: Went to bed and woke up at 4 am to pee. Afterwards I blacked out and work up on the bathroom floor; Anaphylaxis; chest hurt to breathe; Itching in my arms and chest in the evening.; rash; This is a spontaneous report from a contactable healthcare professional (patient).   A 60-years-old non-pregnant female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Left arm on 15Mar2021 at 17:00 (Batch/Lot Number: EP8534) as SINGLE DOSE for covid-19 immunisation. Medical history included Only occasional migraines. Never anything like this and known allergies: Some grasses. The patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medications included probiotics (PROBIOTICS) taken for an unspecified indication, start and stop date were not reported; betaine hydrochloride, bromelains, cellulase, pancreatin, papain (DIGESTIVE ENZYMES) taken for an unspecified indication, start and stop date were not reported.  On 18Mar2021, at 8pm, the patient reported that "3 days after 2nd shot I started itching in my arms and chest in the evening. Went to bed and woke up at 4 am to pee. Afterwards I blacked out and work up on the bathroom floor. My rash was worse and spreading and chest hurt to breathe and I had bumps on head so we called # and nurse and my husband drove me to (Name). They gave me an IV and epinephrine shot and Pepcid and did CT scan of head and blood work. Diagnosed Anaphylaxis. They sent me home a couple hours later with prescription for Epi pens Zyrtec and Famotidine. Over the course of Friday my rash/hives got worse and spread over my body and my lips /mouth started to swell. I called the nurse who suggested I come back in and they checked by throat to ensure it wasn't closing up and gave me ibuprofen and Benadryl and sent me home. Rash/hives worse and spread all over body and face when I woke up Saturday morning (today). Plan to see specialist Sunday or Monday." The outcome of the events was not recovered. The patient was not tested for COVID-19 after vaccination.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Loss of consciousness, Pruritus, Rash, Urticaria
Clinical narrative: Went to bed and woke up at 4 am to pee. Afterwards I blacked out and work up on the bathroom floor; Anaphylaxis; chest hurt to breathe; Itching in my arms and chest in the evening.; rash; This is a spontaneous report from a contactable healthcare professional (patient).   A 60-years-old non-pregnant female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Left arm on 15Mar2021 at 17:00 (Batch/Lot Number: EP8534) as SINGLE DOSE for covid-19 immunisation. Medical history included Only occasional migraines. Never anything like this and known allergies: Some grasses. The patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medications included probiotics (PROBIOTICS) taken for an unspecified indication, start and stop date were not reported; betaine hydrochloride, bromelains, cellulase, pancreatin, papain (DIGESTIVE ENZYMES) taken for an unspecified indication, start and stop date were not reported.  On 18Mar2021, at 8pm, the patient reported that "3 days after 2nd shot I started itching in my arms and chest in the evening. Went to bed and woke up at 4 am to pee. Afterwards I blacked out and work up on the bathroom floor. My rash was worse and spreading and chest hurt to breathe and I had bumps on head so we called # and nurse and my husband drove me to (Name). They gave me an IV and epinephrine shot and Pepcid and did CT scan of head and blood work. Diagnosed Anaphylaxis. They sent me home a couple hours later with prescription for Epi pens Zyrtec and Famotidine. Over the course of Friday my rash/hives got worse and spread over my body and my lips /mouth started to swell. I called the nurse who suggested I come back in and they checked by throat to ensure it wasn't closing up and gave me ibuprofen and Benadryl and sent me home. Rash/hives worse and spread all over body and face when I woke up Saturday morning (today). Plan to see specialist Sunday or Monday." The outcome of the events was not recovered. The patient was not tested for COVID-19 after vaccination.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anaphylactic reaction, Blood test, Computerised tomogram, Dyspnoea, Loss of consciousness
Clinical narrative: Went to bed and woke up at 4 am to pee. Afterwards I blacked out and work up on the bathroom floor; Anaphylaxis; chest hurt to breathe; Itching in my arms and chest in the evening.; rash; This is a spontaneous report from a contactable healthcare professional (patient).   A 60-years-old non-pregnant female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Left arm on 15Mar2021 at 17:00 (Batch/Lot Number: EP8534) as SINGLE DOSE for covid-19 immunisation. Medical history included Only occasional migraines. Never anything like this and known allergies: Some grasses. The patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medications included probiotics (PROBIOTICS) taken for an unspecified indication, start and stop date were not reported; betaine hydrochloride, bromelains, cellulase, pancreatin, papain (DIGESTIVE ENZYMES) taken for an unspecified indication, start and stop date were not reported.  On 18Mar2021, at 8pm, the patient reported that "3 days after 2nd shot I started itching in my arms and chest in the evening. Went to bed and woke up at 4 am to pee. Afterwards I blacked out and work up on the bathroom floor. My rash was worse and spreading and chest hurt to breathe and I had bumps on head so we called # and nurse and my husband drove me to (Name). They gave me an IV and epinephrine shot and Pepcid and did CT scan of head and blood work. Diagnosed Anaphylaxis. They sent me home a couple hours later with prescription for Epi pens Zyrtec and Famotidine. Over the course of Friday my rash/hives got worse and spread over my body and my lips /mouth started to swell. I called the nurse who suggested I come back in and they checked by throat to ensure it wasn't closing up and gave me ibuprofen and Benadryl and sent me home. Rash/hives worse and spread all over body and face when I woke up Saturday morning (today). Plan to see specialist Sunday or Monday." The outcome of the events was not recovered. The patient was not tested for COVID-19 after vaccination.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pruritus, Rash
Clinical narrative: Went to bed and woke up at 4 am to pee. Afterwards I blacked out and work up on the bathroom floor; Anaphylaxis; chest hurt to breathe; Itching in my arms and chest in the evening.; rash; This is a spontaneous report from a contactable healthcare professional (patient).   A 60-years-old non-pregnant female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Left arm on 15Mar2021 at 17:00 (Batch/Lot Number: EP8534) as SINGLE DOSE for covid-19 immunisation. Medical history included Only occasional migraines. Never anything like this and known allergies: Some grasses. The patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medications included probiotics (PROBIOTICS) taken for an unspecified indication, start and stop date were not reported; betaine hydrochloride, bromelains, cellulase, pancreatin, papain (DIGESTIVE ENZYMES) taken for an unspecified indication, start and stop date were not reported.  On 18Mar2021, at 8pm, the patient reported that "3 days after 2nd shot I started itching in my arms and chest in the evening. Went to bed and woke up at 4 am to pee. Afterwards I blacked out and work up on the bathroom floor. My rash was worse and spreading and chest hurt to breathe and I had bumps on head so we called # and nurse and my husband drove me to (Name). They gave me an IV and epinephrine shot and Pepcid and did CT scan of head and blood work. Diagnosed Anaphylaxis. They sent me home a couple hours later with prescription for Epi pens Zyrtec and Famotidine. Over the course of Friday my rash/hives got worse and spread over my body and my lips /mouth started to swell. I called the nurse who suggested I come back in and they checked by throat to ensure it wasn't closing up and gave me ibuprofen and Benadryl and sent me home. Rash/hives worse and spread all over body and face when I woke up Saturday morning (today). Plan to see specialist Sunday or Monday." The outcome of the events was not recovered. The patient was not tested for COVID-19 after vaccination.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram head abnormal, Ear pain, Erythema, Feeling hot, Headache
Clinical narrative: EAR ACHE; SORE ARM; TOOTHACHE; TRIGEMINAL NEURALGIA; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included pollen allergy, non alcohol user, and non-smoker, and other pre-existing medical conditions included the patient did not have any drug abuse/illicit drug use.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1802072, expiry: UNKNOWN) dose was not reported, administered on 06-MAR-2021 to left deltoid for prophylactic vaccination. No concomitant medications were reported. On 2021, the subject experienced trigeminal neuralgia. On MAR-2021, the subject experienced toothache. On 07-MAR-2021, the subject experienced ear ache. On 07-MAR-2021, the subject experienced sore arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sore arm on 08-MAR-2021, had not recovered from ear ache, and toothache, and the outcome of trigeminal neuralgia was not reported. This report was non-serious.; Sender's Comments: V0: Medical assessment comment not required as per standard procedure as case assessed as non serious.